Highly Accessed Commentary

Biosimilars: a regulatory perspective from America

Jonathan Kay

Arthritis Research & Therapy 2011, 13:112 doi:10.1186/ar3310

Accesses  

  • Last 30 days: 224 accesses
  • Last 365 days: 3357 accesses
  • All time: 7057 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations